A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience
Crossref DOI link: https://doi.org/10.1186/s10194-016-0591-3
Published Online: 2016-01-21
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Negro, Andrea
Curto, Martina
Lionetto, Luana
Martelletti, Paolo
Funding for this research was provided by:
Allergan
License valid from 2015-12-01